Literature DB >> 20413316

Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery.

Matthias Thielmann1, Achmet Mechmet, Markus Neuhäuser, Daniel Wendt, Paschalis Tossios, Ali Canbay, Parwis Massoudy, Heinz Jakob.   

Abstract

OBJECTIVE: There are few data assessing factors, which identify patients with liver cirrhosis (LC) facing high risk for open-heart surgery. We sought to compare the Model for End-Stage Liver Disease (MELD) score, the Child-Turcotte-Pugh (CTP) classification and the European system for cardiac operative risk evaluation (EuroSCORE) for risk prediction in cirrhotic patients.
METHODS: Fifty-seven consecutive patients with non-cardiac LC, who underwent open-heart surgery with the use of cardiopulmonary bypass between 1998 and 2008, were studied at our institution. Potential preoperative predictors of outcome, as well as preoperative MELD score, CTP classification and EuroSCORE were calculated. The primary study end points were all-cause in-hospital and long-term mortality.
RESULTS: MELD score and CTP classification both differed significantly between survivors and non-survivors for in-hospital (P<0.0001) and long-term mortality (P<0.0001). Univariate predictors of in-hospital mortality were emergency surgery (odds ratio (OR), 4.9; 95% confidence interval (CI), 1.2-20.6; P=0.03), ascites (OR, 7.2; 95% CI, 2.0-25.5; P=0.002), total serum protein (OR, 0.4; 95% CI, 0.2-0.8; P=0.01), CTP class (OR, 5.5; 95% CI, 1.4-21.5; P=0.04) and MELD score (OR, 1.4; 95% CI, 1.1-1.6; P=0.001). Multivariable exact logistic regression analyses revealed MELD score (OR, 1.3; 95% CI, 1.005-1.6; P=0.04) as the only independent factor associated with in-hospital mortality. Receiver operating characteristic curve (ROC) analysis showed MELD score to be highly predictive with an optimal cut-off value of 13.5 (sensitivity: 82.0%, specificity: 78.5%) for postoperative in-hospital mortality (area under curve (AUC): 85.1 ± 0.05%) and superior compared to the CTP classification (AUC: 75.7±0.08%) and EuroSCORE (AUC: 65.9 ± 0.08%).
CONCLUSIONS: The mortality of patients with liver cirrhosis undergoing open-heart surgery progressively increases with the severity of liver dysfunction. Therefore, the MELD score most reliably identifies those cirrhotic patients who are at high risk for open-heart surgery.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20413316     DOI: 10.1016/j.ejcts.2010.02.042

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  Postoperative usage of tolvaptan in a patient with aortic valve stenosis complicated by Child-Pugh classification B liver cirrhosis and hepatic edema.

Authors:  Yasunori Iida; Tsutomu Ito; Sachiko Hayashi; Tatsuo Takahashi; Takahiko Misumi
Journal:  CEN Case Rep       Date:  2014-10-21

2.  eComment. The prognostic role of the MELD score in cardiac surgery patients with cirrhosis.

Authors:  Paschalis Tossios; Avgerinos Karatzopoulos; Matthias Thielmann
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03

3.  Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality.

Authors:  Cheng-Hsin Lin; Ron-Bin Hsu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  In-Hospital mortality varies by procedure type among cirrhosis surgery admissions.

Authors:  Nadim Mahmud; Zachary Fricker; Marina Serper; David E Kaplan; Kenneth D Rothstein; David S Goldberg
Journal:  Liver Int       Date:  2019-06-17       Impact factor: 5.828

5.  Model for End-Stage Liver Disease Score Independently Predicts Mortality in Cardiac Surgery.

Authors:  Robert B Hawkins; Bree Ann C Young; J Hunter Mehaffey; Alan M Speir; Mohammed A Quader; Jeffrey B Rich; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2019-01-09       Impact factor: 4.330

6.  Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.

Authors:  Muhammad Z Khan; Muhammad U Khan; Muhammad Bilal Munir; Safi U Khan; Mohammed Osman; Sudarshan Balla
Journal:  Catheter Cardiovasc Interv       Date:  2020-03-04       Impact factor: 2.692

Review 7.  Influence of cirrhosis in cardiac surgery outcomes.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Josep L Ventura; Rafael Mañez; Elisabet Farrero; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio
Journal:  World J Hepatol       Date:  2015-04-18

8.  Short-term independent mortality risk factors in patients with cirrhosis undergoing cardiac surgery.

Authors:  Juan Carlos Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Xose Perez; Herminia Torrado; Maria L Carrio; David Rodríguez-Castro; Elisabet Farrero; Josep Lluís Ventura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-12

Review 9.  Neurosurgical procedures in patients with liver cirrhosis: A review.

Authors:  Ching-Chang Chen; Yin-Cheng Huang; Chun-Nan Yeh
Journal:  World J Hepatol       Date:  2015-09-28

10.  Liver dysfunction as an important predicting risk factor in patients undergoing cardiac surgery: a systematic review and meta-analysis.

Authors:  Wan Chin Hsieh; Po Chen Chen; Flavia-Catalina Corciova; Grigore Tinica
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.